Abstract
This article discusses the responsibilities of the Drug Surveillance Department at A. H. Robins, the methods by which the Department receives spontaneous adverse reaction data, and the protocol used to obtain follow-up data. It further reviews the items of data requested from reporters of adverse reactions and the methods by which this data can be graphically represented.
Get full access to this article
View all access options for this article.
